Brief: Cosmo Full-Year Sees FY Revenue Eur 60 Million To Eur 64 Million
March 26 (Reuters) - Cosmo Pharmaceuticals NV COPN.S :
* COSMO FULL-YEAR REPORT 2020: COSMO RETURNS TO OPERATING
PROFIT
* SEES FY REVENUE EUR 60 MILLION TO EUR 64 MILLION
* SEES 2021 TOTAL EXPENSES IN RANGE OF EUR 57 - EUR 59
MILLION
* SEES 2021 OPERATING PROFIT IN RANGE OF EUR 3 - EUR 5
MILLION
Source text for Eikon: ID:nPn4LQDtfa
Further company coverage: COPN.S
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cosmo NV
See all newsFocus: Beyond the Scale: Men turn to cosmetic clinics to complete weight-loss transformation
Ireland's Cosmo recurring revenue rises on winlevi growth, reaffirms FY guidance
Brief: Cosmo Pharmaceuticals H1 EPS EUR -0.279
Cosmo Pharma's male hair loss treatment shows sustained hair growth in year‑long study
Europe Research Roundup: Airbus ,Bechtle, Salzgitter